Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
When your patients need sacral neuromodulation, choose the only systems with proven, long-term clinical results.1-3
years SNM experience
How the InterStim™ systems work
With the InterStim™ systems, the implanted neurostimulator and lead stimulate the sacral nerve. Evidence suggests that this may restore neural communication between the bladder and brain and between the bowel and brain.4,5 Unlike oral medications that target the muscular component of bladder control, the InterStim™ systems offer symptom control through direct modulation of nerve activity.4,5
Powerful. Personalized. Proven.
The most common adverse events experienced during clinical studies include pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.
Complications can occur with the evaluation, including tissue damage, infection, and technical problems with the device. Patients should be instructed on operating the programmer and given precautions related to the evaluation.
Engineered by Medtronic
Medtronic is one of the most trusted global leaders in healthcare innovation and has been serving patients across the globe since 1949.
In the past year, Medtronic therapies improved the lives of 72 million people. That’s two people every second of every hour of every day — and counting.
Under certain conditions. See approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only.
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018; 229–236.
Medtronic InterStim Therapy Clinical Summary (2018).
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):23.
Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11-18.
Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100:959–968.